Global Influenza Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Influenza Therapeutics market size was valued at USD 6836.6 million in 2023 and is forecast to a readjusted size of USD 9362.1 million by 2030 with a CAGR of 4.6% during review period.
Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Influenza Therapeutics industry chain, the market status of Hospitals (Vaccines, Drugs), Clinic (Vaccines, Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Therapeutics.
Regionally, the report analyzes the Influenza Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Influenza Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Vaccines, Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Therapeutics market.
Regional Analysis: The report involves examining the Influenza Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Influenza Therapeutics:
Company Analysis: Report covers individual Influenza Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinic).
Technology Analysis: Report covers specific technologies relevant to Influenza Therapeutics. It assesses the current state, advancements, and potential future developments in Influenza Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Influenza Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Influenza Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Influenza Therapeutics, with revenue, gross margin and global market share of Influenza Therapeutics from 2019 to 2024.
Chapter 3, the Influenza Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Influenza Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Therapeutics.
Chapter 13, to describe Influenza Therapeutics research findings and conclusion.
Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Influenza Therapeutics industry chain, the market status of Hospitals (Vaccines, Drugs), Clinic (Vaccines, Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Therapeutics.
Regionally, the report analyzes the Influenza Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Influenza Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Vaccines, Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Therapeutics market.
Regional Analysis: The report involves examining the Influenza Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Influenza Therapeutics:
Company Analysis: Report covers individual Influenza Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinic).
Technology Analysis: Report covers specific technologies relevant to Influenza Therapeutics. It assesses the current state, advancements, and potential future developments in Influenza Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Influenza Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Vaccines
- Drugs
- Hospitals
- Clinic
- Others
- Abbott Laboratories
- Astrazeneca PLC
- Biocryst Pharmaceuticals, Inc.
- Chiron Corporation
- CSL Limited
- Daiichi Sankyo Co., Ltd.
- Glaxosmithkline PLC
- Mitsubishi Tanabe Pharma Corporation
- Nanotherapeutics Inc.
- Protein Sciences Corporation
- Roche Holding AG
- Sanofi SA
- Shionogi & Co., Ltd.
- Sinovac Biotech Ltd.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Influenza Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Influenza Therapeutics, with revenue, gross margin and global market share of Influenza Therapeutics from 2019 to 2024.
Chapter 3, the Influenza Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Influenza Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Therapeutics.
Chapter 13, to describe Influenza Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Influenza Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Influenza Therapeutics by Type
1.3.1 Overview: Global Influenza Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Influenza Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Vaccines
1.3.4 Drugs
1.4 Global Influenza Therapeutics Market by Application
1.4.1 Overview: Global Influenza Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinic
1.4.4 Others
1.5 Global Influenza Therapeutics Market Size & Forecast
1.6 Global Influenza Therapeutics Market Size and Forecast by Region
1.6.1 Global Influenza Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Influenza Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Influenza Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Influenza Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Influenza Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Influenza Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Influenza Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Influenza Therapeutics Product and Solutions
2.1.4 Abbott Laboratories Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Astrazeneca PLC
2.2.1 Astrazeneca PLC Details
2.2.2 Astrazeneca PLC Major Business
2.2.3 Astrazeneca PLC Influenza Therapeutics Product and Solutions
2.2.4 Astrazeneca PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Astrazeneca PLC Recent Developments and Future Plans
2.3 Biocryst Pharmaceuticals, Inc.
2.3.1 Biocryst Pharmaceuticals, Inc. Details
2.3.2 Biocryst Pharmaceuticals, Inc. Major Business
2.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product and Solutions
2.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biocryst Pharmaceuticals, Inc. Recent Developments and Future Plans
2.4 Chiron Corporation
2.4.1 Chiron Corporation Details
2.4.2 Chiron Corporation Major Business
2.4.3 Chiron Corporation Influenza Therapeutics Product and Solutions
2.4.4 Chiron Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Chiron Corporation Recent Developments and Future Plans
2.5 CSL Limited
2.5.1 CSL Limited Details
2.5.2 CSL Limited Major Business
2.5.3 CSL Limited Influenza Therapeutics Product and Solutions
2.5.4 CSL Limited Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CSL Limited Recent Developments and Future Plans
2.6 Daiichi Sankyo Co., Ltd.
2.6.1 Daiichi Sankyo Co., Ltd. Details
2.6.2 Daiichi Sankyo Co., Ltd. Major Business
2.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product and Solutions
2.6.4 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Daiichi Sankyo Co., Ltd. Recent Developments and Future Plans
2.7 Glaxosmithkline PLC
2.7.1 Glaxosmithkline PLC Details
2.7.2 Glaxosmithkline PLC Major Business
2.7.3 Glaxosmithkline PLC Influenza Therapeutics Product and Solutions
2.7.4 Glaxosmithkline PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Glaxosmithkline PLC Recent Developments and Future Plans
2.8 Mitsubishi Tanabe Pharma Corporation
2.8.1 Mitsubishi Tanabe Pharma Corporation Details
2.8.2 Mitsubishi Tanabe Pharma Corporation Major Business
2.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product and Solutions
2.8.4 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
2.9 Nanotherapeutics Inc.
2.9.1 Nanotherapeutics Inc. Details
2.9.2 Nanotherapeutics Inc. Major Business
2.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product and Solutions
2.9.4 Nanotherapeutics Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nanotherapeutics Inc. Recent Developments and Future Plans
2.10 Protein Sciences Corporation
2.10.1 Protein Sciences Corporation Details
2.10.2 Protein Sciences Corporation Major Business
2.10.3 Protein Sciences Corporation Influenza Therapeutics Product and Solutions
2.10.4 Protein Sciences Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Protein Sciences Corporation Recent Developments and Future Plans
2.11 Roche Holding AG
2.11.1 Roche Holding AG Details
2.11.2 Roche Holding AG Major Business
2.11.3 Roche Holding AG Influenza Therapeutics Product and Solutions
2.11.4 Roche Holding AG Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Roche Holding AG Recent Developments and Future Plans
2.12 Sanofi SA
2.12.1 Sanofi SA Details
2.12.2 Sanofi SA Major Business
2.12.3 Sanofi SA Influenza Therapeutics Product and Solutions
2.12.4 Sanofi SA Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sanofi SA Recent Developments and Future Plans
2.13 Shionogi & Co., Ltd.
2.13.1 Shionogi & Co., Ltd. Details
2.13.2 Shionogi & Co., Ltd. Major Business
2.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Product and Solutions
2.13.4 Shionogi & Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Shionogi & Co., Ltd. Recent Developments and Future Plans
2.14 Sinovac Biotech Ltd.
2.14.1 Sinovac Biotech Ltd. Details
2.14.2 Sinovac Biotech Ltd. Major Business
2.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product and Solutions
2.14.4 Sinovac Biotech Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Sinovac Biotech Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Influenza Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Influenza Therapeutics by Company Revenue
3.2.2 Top 3 Influenza Therapeutics Players Market Share in 2023
3.2.3 Top 6 Influenza Therapeutics Players Market Share in 2023
3.3 Influenza Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Influenza Therapeutics Market: Region Footprint
3.3.2 Influenza Therapeutics Market: Company Product Type Footprint
3.3.3 Influenza Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Influenza Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Influenza Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Influenza Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Influenza Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Influenza Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Influenza Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Influenza Therapeutics Market Size by Country
6.3.1 North America Influenza Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Influenza Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Influenza Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Influenza Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Influenza Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Influenza Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Influenza Therapeutics Market Size by Country
7.3.1 Europe Influenza Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Influenza Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Influenza Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Influenza Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Influenza Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Influenza Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Influenza Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Influenza Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Influenza Therapeutics Market Size by Region
8.3.1 Asia-Pacific Influenza Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Influenza Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Influenza Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Influenza Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Influenza Therapeutics Market Size by Country
9.3.1 South America Influenza Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Influenza Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Influenza Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Influenza Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Influenza Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Influenza Therapeutics Market Size by Country
10.3.1 Middle East & Africa Influenza Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Influenza Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Influenza Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Influenza Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Influenza Therapeutics Market Drivers
11.2 Influenza Therapeutics Market Restraints
11.3 Influenza Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Influenza Therapeutics Industry Chain
12.2 Influenza Therapeutics Upstream Analysis
12.3 Influenza Therapeutics Midstream Analysis
12.4 Influenza Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Influenza Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Influenza Therapeutics by Type
1.3.1 Overview: Global Influenza Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Influenza Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Vaccines
1.3.4 Drugs
1.4 Global Influenza Therapeutics Market by Application
1.4.1 Overview: Global Influenza Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinic
1.4.4 Others
1.5 Global Influenza Therapeutics Market Size & Forecast
1.6 Global Influenza Therapeutics Market Size and Forecast by Region
1.6.1 Global Influenza Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Influenza Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Influenza Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Influenza Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Influenza Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Influenza Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Influenza Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Influenza Therapeutics Product and Solutions
2.1.4 Abbott Laboratories Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Astrazeneca PLC
2.2.1 Astrazeneca PLC Details
2.2.2 Astrazeneca PLC Major Business
2.2.3 Astrazeneca PLC Influenza Therapeutics Product and Solutions
2.2.4 Astrazeneca PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Astrazeneca PLC Recent Developments and Future Plans
2.3 Biocryst Pharmaceuticals, Inc.
2.3.1 Biocryst Pharmaceuticals, Inc. Details
2.3.2 Biocryst Pharmaceuticals, Inc. Major Business
2.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product and Solutions
2.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biocryst Pharmaceuticals, Inc. Recent Developments and Future Plans
2.4 Chiron Corporation
2.4.1 Chiron Corporation Details
2.4.2 Chiron Corporation Major Business
2.4.3 Chiron Corporation Influenza Therapeutics Product and Solutions
2.4.4 Chiron Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Chiron Corporation Recent Developments and Future Plans
2.5 CSL Limited
2.5.1 CSL Limited Details
2.5.2 CSL Limited Major Business
2.5.3 CSL Limited Influenza Therapeutics Product and Solutions
2.5.4 CSL Limited Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CSL Limited Recent Developments and Future Plans
2.6 Daiichi Sankyo Co., Ltd.
2.6.1 Daiichi Sankyo Co., Ltd. Details
2.6.2 Daiichi Sankyo Co., Ltd. Major Business
2.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product and Solutions
2.6.4 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Daiichi Sankyo Co., Ltd. Recent Developments and Future Plans
2.7 Glaxosmithkline PLC
2.7.1 Glaxosmithkline PLC Details
2.7.2 Glaxosmithkline PLC Major Business
2.7.3 Glaxosmithkline PLC Influenza Therapeutics Product and Solutions
2.7.4 Glaxosmithkline PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Glaxosmithkline PLC Recent Developments and Future Plans
2.8 Mitsubishi Tanabe Pharma Corporation
2.8.1 Mitsubishi Tanabe Pharma Corporation Details
2.8.2 Mitsubishi Tanabe Pharma Corporation Major Business
2.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product and Solutions
2.8.4 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
2.9 Nanotherapeutics Inc.
2.9.1 Nanotherapeutics Inc. Details
2.9.2 Nanotherapeutics Inc. Major Business
2.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product and Solutions
2.9.4 Nanotherapeutics Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nanotherapeutics Inc. Recent Developments and Future Plans
2.10 Protein Sciences Corporation
2.10.1 Protein Sciences Corporation Details
2.10.2 Protein Sciences Corporation Major Business
2.10.3 Protein Sciences Corporation Influenza Therapeutics Product and Solutions
2.10.4 Protein Sciences Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Protein Sciences Corporation Recent Developments and Future Plans
2.11 Roche Holding AG
2.11.1 Roche Holding AG Details
2.11.2 Roche Holding AG Major Business
2.11.3 Roche Holding AG Influenza Therapeutics Product and Solutions
2.11.4 Roche Holding AG Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Roche Holding AG Recent Developments and Future Plans
2.12 Sanofi SA
2.12.1 Sanofi SA Details
2.12.2 Sanofi SA Major Business
2.12.3 Sanofi SA Influenza Therapeutics Product and Solutions
2.12.4 Sanofi SA Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sanofi SA Recent Developments and Future Plans
2.13 Shionogi & Co., Ltd.
2.13.1 Shionogi & Co., Ltd. Details
2.13.2 Shionogi & Co., Ltd. Major Business
2.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Product and Solutions
2.13.4 Shionogi & Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Shionogi & Co., Ltd. Recent Developments and Future Plans
2.14 Sinovac Biotech Ltd.
2.14.1 Sinovac Biotech Ltd. Details
2.14.2 Sinovac Biotech Ltd. Major Business
2.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product and Solutions
2.14.4 Sinovac Biotech Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Sinovac Biotech Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Influenza Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Influenza Therapeutics by Company Revenue
3.2.2 Top 3 Influenza Therapeutics Players Market Share in 2023
3.2.3 Top 6 Influenza Therapeutics Players Market Share in 2023
3.3 Influenza Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Influenza Therapeutics Market: Region Footprint
3.3.2 Influenza Therapeutics Market: Company Product Type Footprint
3.3.3 Influenza Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Influenza Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Influenza Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Influenza Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Influenza Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Influenza Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Influenza Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Influenza Therapeutics Market Size by Country
6.3.1 North America Influenza Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Influenza Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Influenza Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Influenza Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Influenza Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Influenza Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Influenza Therapeutics Market Size by Country
7.3.1 Europe Influenza Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Influenza Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Influenza Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Influenza Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Influenza Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Influenza Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Influenza Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Influenza Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Influenza Therapeutics Market Size by Region
8.3.1 Asia-Pacific Influenza Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Influenza Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Influenza Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Influenza Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Influenza Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Influenza Therapeutics Market Size by Country
9.3.1 South America Influenza Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Influenza Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Influenza Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Influenza Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Influenza Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Influenza Therapeutics Market Size by Country
10.3.1 Middle East & Africa Influenza Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Influenza Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Influenza Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Influenza Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Influenza Therapeutics Market Drivers
11.2 Influenza Therapeutics Market Restraints
11.3 Influenza Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Influenza Therapeutics Industry Chain
12.2 Influenza Therapeutics Upstream Analysis
12.3 Influenza Therapeutics Midstream Analysis
12.4 Influenza Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Influenza Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Influenza Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Influenza Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Influenza Therapeutics Product and Solutions
Table 8. Abbott Laboratories Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Astrazeneca PLC Company Information, Head Office, and Major Competitors
Table 11. Astrazeneca PLC Major Business
Table 12. Astrazeneca PLC Influenza Therapeutics Product and Solutions
Table 13. Astrazeneca PLC Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Astrazeneca PLC Recent Developments and Future Plans
Table 15. Biocryst Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 16. Biocryst Pharmaceuticals, Inc. Major Business
Table 17. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product and Solutions
Table 18. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Biocryst Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 20. Chiron Corporation Company Information, Head Office, and Major Competitors
Table 21. Chiron Corporation Major Business
Table 22. Chiron Corporation Influenza Therapeutics Product and Solutions
Table 23. Chiron Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Chiron Corporation Recent Developments and Future Plans
Table 25. CSL Limited Company Information, Head Office, and Major Competitors
Table 26. CSL Limited Major Business
Table 27. CSL Limited Influenza Therapeutics Product and Solutions
Table 28. CSL Limited Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. CSL Limited Recent Developments and Future Plans
Table 30. Daiichi Sankyo Co., Ltd. Company Information, Head Office, and Major Competitors
Table 31. Daiichi Sankyo Co., Ltd. Major Business
Table 32. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product and Solutions
Table 33. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Daiichi Sankyo Co., Ltd. Recent Developments and Future Plans
Table 35. Glaxosmithkline PLC Company Information, Head Office, and Major Competitors
Table 36. Glaxosmithkline PLC Major Business
Table 37. Glaxosmithkline PLC Influenza Therapeutics Product and Solutions
Table 38. Glaxosmithkline PLC Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Glaxosmithkline PLC Recent Developments and Future Plans
Table 40. Mitsubishi Tanabe Pharma Corporation Company Information, Head Office, and Major Competitors
Table 41. Mitsubishi Tanabe Pharma Corporation Major Business
Table 42. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product and Solutions
Table 43. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
Table 45. Nanotherapeutics Inc. Company Information, Head Office, and Major Competitors
Table 46. Nanotherapeutics Inc. Major Business
Table 47. Nanotherapeutics Inc. Influenza Therapeutics Product and Solutions
Table 48. Nanotherapeutics Inc. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Nanotherapeutics Inc. Recent Developments and Future Plans
Table 50. Protein Sciences Corporation Company Information, Head Office, and Major Competitors
Table 51. Protein Sciences Corporation Major Business
Table 52. Protein Sciences Corporation Influenza Therapeutics Product and Solutions
Table 53. Protein Sciences Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Protein Sciences Corporation Recent Developments and Future Plans
Table 55. Roche Holding AG Company Information, Head Office, and Major Competitors
Table 56. Roche Holding AG Major Business
Table 57. Roche Holding AG Influenza Therapeutics Product and Solutions
Table 58. Roche Holding AG Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Roche Holding AG Recent Developments and Future Plans
Table 60. Sanofi SA Company Information, Head Office, and Major Competitors
Table 61. Sanofi SA Major Business
Table 62. Sanofi SA Influenza Therapeutics Product and Solutions
Table 63. Sanofi SA Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Sanofi SA Recent Developments and Future Plans
Table 65. Shionogi & Co., Ltd. Company Information, Head Office, and Major Competitors
Table 66. Shionogi & Co., Ltd. Major Business
Table 67. Shionogi & Co., Ltd. Influenza Therapeutics Product and Solutions
Table 68. Shionogi & Co., Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Shionogi & Co., Ltd. Recent Developments and Future Plans
Table 70. Sinovac Biotech Ltd. Company Information, Head Office, and Major Competitors
Table 71. Sinovac Biotech Ltd. Major Business
Table 72. Sinovac Biotech Ltd. Influenza Therapeutics Product and Solutions
Table 73. Sinovac Biotech Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Sinovac Biotech Ltd. Recent Developments and Future Plans
Table 75. Global Influenza Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 76. Global Influenza Therapeutics Revenue Share by Players (2019-2024)
Table 77. Breakdown of Influenza Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Influenza Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Influenza Therapeutics Players
Table 80. Influenza Therapeutics Market: Company Product Type Footprint
Table 81. Influenza Therapeutics Market: Company Product Application Footprint
Table 82. Influenza Therapeutics New Market Entrants and Barriers to Market Entry
Table 83. Influenza Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Influenza Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Influenza Therapeutics Consumption Value Share by Type (2019-2024)
Table 86. Global Influenza Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 87. Global Influenza Therapeutics Consumption Value by Application (2019-2024)
Table 88. Global Influenza Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 89. North America Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Influenza Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Influenza Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Influenza Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Influenza Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Influenza Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Influenza Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Influenza Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Influenza Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Influenza Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Influenza Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Influenza Therapeutics Raw Material
Table 120. Key Suppliers of Influenza Therapeutics Raw Materials
Table 1. Global Influenza Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Influenza Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Influenza Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Influenza Therapeutics Product and Solutions
Table 8. Abbott Laboratories Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Astrazeneca PLC Company Information, Head Office, and Major Competitors
Table 11. Astrazeneca PLC Major Business
Table 12. Astrazeneca PLC Influenza Therapeutics Product and Solutions
Table 13. Astrazeneca PLC Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Astrazeneca PLC Recent Developments and Future Plans
Table 15. Biocryst Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 16. Biocryst Pharmaceuticals, Inc. Major Business
Table 17. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product and Solutions
Table 18. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Biocryst Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 20. Chiron Corporation Company Information, Head Office, and Major Competitors
Table 21. Chiron Corporation Major Business
Table 22. Chiron Corporation Influenza Therapeutics Product and Solutions
Table 23. Chiron Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Chiron Corporation Recent Developments and Future Plans
Table 25. CSL Limited Company Information, Head Office, and Major Competitors
Table 26. CSL Limited Major Business
Table 27. CSL Limited Influenza Therapeutics Product and Solutions
Table 28. CSL Limited Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. CSL Limited Recent Developments and Future Plans
Table 30. Daiichi Sankyo Co., Ltd. Company Information, Head Office, and Major Competitors
Table 31. Daiichi Sankyo Co., Ltd. Major Business
Table 32. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product and Solutions
Table 33. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Daiichi Sankyo Co., Ltd. Recent Developments and Future Plans
Table 35. Glaxosmithkline PLC Company Information, Head Office, and Major Competitors
Table 36. Glaxosmithkline PLC Major Business
Table 37. Glaxosmithkline PLC Influenza Therapeutics Product and Solutions
Table 38. Glaxosmithkline PLC Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Glaxosmithkline PLC Recent Developments and Future Plans
Table 40. Mitsubishi Tanabe Pharma Corporation Company Information, Head Office, and Major Competitors
Table 41. Mitsubishi Tanabe Pharma Corporation Major Business
Table 42. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product and Solutions
Table 43. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
Table 45. Nanotherapeutics Inc. Company Information, Head Office, and Major Competitors
Table 46. Nanotherapeutics Inc. Major Business
Table 47. Nanotherapeutics Inc. Influenza Therapeutics Product and Solutions
Table 48. Nanotherapeutics Inc. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Nanotherapeutics Inc. Recent Developments and Future Plans
Table 50. Protein Sciences Corporation Company Information, Head Office, and Major Competitors
Table 51. Protein Sciences Corporation Major Business
Table 52. Protein Sciences Corporation Influenza Therapeutics Product and Solutions
Table 53. Protein Sciences Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Protein Sciences Corporation Recent Developments and Future Plans
Table 55. Roche Holding AG Company Information, Head Office, and Major Competitors
Table 56. Roche Holding AG Major Business
Table 57. Roche Holding AG Influenza Therapeutics Product and Solutions
Table 58. Roche Holding AG Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Roche Holding AG Recent Developments and Future Plans
Table 60. Sanofi SA Company Information, Head Office, and Major Competitors
Table 61. Sanofi SA Major Business
Table 62. Sanofi SA Influenza Therapeutics Product and Solutions
Table 63. Sanofi SA Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Sanofi SA Recent Developments and Future Plans
Table 65. Shionogi & Co., Ltd. Company Information, Head Office, and Major Competitors
Table 66. Shionogi & Co., Ltd. Major Business
Table 67. Shionogi & Co., Ltd. Influenza Therapeutics Product and Solutions
Table 68. Shionogi & Co., Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Shionogi & Co., Ltd. Recent Developments and Future Plans
Table 70. Sinovac Biotech Ltd. Company Information, Head Office, and Major Competitors
Table 71. Sinovac Biotech Ltd. Major Business
Table 72. Sinovac Biotech Ltd. Influenza Therapeutics Product and Solutions
Table 73. Sinovac Biotech Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Sinovac Biotech Ltd. Recent Developments and Future Plans
Table 75. Global Influenza Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 76. Global Influenza Therapeutics Revenue Share by Players (2019-2024)
Table 77. Breakdown of Influenza Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Influenza Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Influenza Therapeutics Players
Table 80. Influenza Therapeutics Market: Company Product Type Footprint
Table 81. Influenza Therapeutics Market: Company Product Application Footprint
Table 82. Influenza Therapeutics New Market Entrants and Barriers to Market Entry
Table 83. Influenza Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Influenza Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Influenza Therapeutics Consumption Value Share by Type (2019-2024)
Table 86. Global Influenza Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 87. Global Influenza Therapeutics Consumption Value by Application (2019-2024)
Table 88. Global Influenza Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 89. North America Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Influenza Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Influenza Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Influenza Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Influenza Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Influenza Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Influenza Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Influenza Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Influenza Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Influenza Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Influenza Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Influenza Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Influenza Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Influenza Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Influenza Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Influenza Therapeutics Raw Material
Table 120. Key Suppliers of Influenza Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. Influenza Therapeutics Picture
Figure 2. Global Influenza Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Vaccines
Figure 5. Drugs
Figure 6. Global Influenza Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Influenza Therapeutics Consumption Value Market Share by Application in 2023
Figure 8. Hospitals Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Influenza Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Influenza Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Influenza Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Influenza Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Influenza Therapeutics Consumption Value Market Share by Region in 2023
Figure 16. North America Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Influenza Therapeutics Revenue Share by Players in 2023
Figure 22. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Influenza Therapeutics Market Share in 2023
Figure 24. Global Top 6 Players Influenza Therapeutics Market Share in 2023
Figure 25. Global Influenza Therapeutics Consumption Value Share by Type (2019-2024)
Figure 26. Global Influenza Therapeutics Market Share Forecast by Type (2025-2030)
Figure 27. Global Influenza Therapeutics Consumption Value Share by Application (2019-2024)
Figure 28. Global Influenza Therapeutics Market Share Forecast by Application (2025-2030)
Figure 29. North America Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Influenza Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Influenza Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. France Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Influenza Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 46. China Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. India Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Influenza Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Influenza Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. Influenza Therapeutics Market Drivers
Figure 64. Influenza Therapeutics Market Restraints
Figure 65. Influenza Therapeutics Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Influenza Therapeutics in 2023
Figure 68. Manufacturing Process Analysis of Influenza Therapeutics
Figure 69. Influenza Therapeutics Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Influenza Therapeutics Picture
Figure 2. Global Influenza Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Vaccines
Figure 5. Drugs
Figure 6. Global Influenza Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Influenza Therapeutics Consumption Value Market Share by Application in 2023
Figure 8. Hospitals Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Influenza Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Influenza Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Influenza Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Influenza Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Influenza Therapeutics Consumption Value Market Share by Region in 2023
Figure 16. North America Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Influenza Therapeutics Revenue Share by Players in 2023
Figure 22. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Influenza Therapeutics Market Share in 2023
Figure 24. Global Top 6 Players Influenza Therapeutics Market Share in 2023
Figure 25. Global Influenza Therapeutics Consumption Value Share by Type (2019-2024)
Figure 26. Global Influenza Therapeutics Market Share Forecast by Type (2025-2030)
Figure 27. Global Influenza Therapeutics Consumption Value Share by Application (2019-2024)
Figure 28. Global Influenza Therapeutics Market Share Forecast by Application (2025-2030)
Figure 29. North America Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Influenza Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Influenza Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. France Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Influenza Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 46. China Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. India Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Influenza Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Influenza Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Influenza Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Influenza Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Influenza Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. Influenza Therapeutics Market Drivers
Figure 64. Influenza Therapeutics Market Restraints
Figure 65. Influenza Therapeutics Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Influenza Therapeutics in 2023
Figure 68. Manufacturing Process Analysis of Influenza Therapeutics
Figure 69. Influenza Therapeutics Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
